Free Trial

Docusign's (DOCU) "Market Outperform" Rating Reaffirmed at JMP Securities

Docusign logo with Computer and Technology background

Key Points

  • Docusign's stock received a "market outperform" rating from JMP Securities with a target price of $124.00, indicating a potential upside of 78.67% from its current price.
  • For the last quarter, Docusign reported earnings per share of $0.92, exceeding expectations and reflecting an 8.8% year-over-year revenue increase to $800.64 million.
  • Docusign has authorized a stock repurchase program worth $1 billion, suggesting that its leadership believes the stock is undervalued.
  • MarketBeat previews top five stocks to own in November.

Docusign (NASDAQ:DOCU - Get Free Report)'s stock had its "market outperform" rating restated by analysts at JMP Securities in a report released on Friday,Benzinga reports. They currently have a $124.00 target price on the stock. JMP Securities' target price suggests a potential upside of 78.67% from the stock's current price.

A number of other equities research analysts have also recently issued reports on DOCU. Robert W. Baird upped their target price on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, September 5th. Wedbush lowered their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday, June 12th. Wall Street Zen raised Docusign from a "hold" rating to a "buy" rating in a research report on Saturday, September 13th. Argus reiterated a "hold" rating on shares of Docusign in a research note on Monday, September 8th. Finally, UBS Group set a $95.00 target price on Docusign in a report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have assigned a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $94.14.

Check Out Our Latest Stock Analysis on Docusign

Docusign Price Performance

Shares of NASDAQ DOCU opened at $69.40 on Friday. The stock has a market capitalization of $13.96 billion, a price-to-earnings ratio of 52.08, a PEG ratio of 3.43 and a beta of 1.02. Docusign has a fifty-two week low of $62.66 and a fifty-two week high of $107.86. The business has a 50-day moving average of $76.37 and a 200-day moving average of $79.20.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period in the previous year, the company earned $0.97 earnings per share. The firm's revenue for the quarter was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, sell-side analysts expect that Docusign will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has authorized a stock repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's leadership believes its shares are undervalued.

Insider Transactions at Docusign

In other Docusign news, CFO Blake Jeffrey Grayson sold 6,500 shares of the stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the transaction, the chief financial officer owned 105,660 shares in the company, valued at $7,522,992. This represents a 5.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director James A. Beer sold 450 shares of Docusign stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $81.28, for a total transaction of $36,576.00. Following the completion of the sale, the director owned 14,199 shares of the company's stock, valued at approximately $1,154,094.72. The trade was a 3.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 96,533 shares of company stock worth $7,281,953. Company insiders own 1.01% of the company's stock.

Institutional Trading of Docusign

Several large investors have recently modified their holdings of DOCU. Norges Bank bought a new position in shares of Docusign in the 2nd quarter valued at $140,987,000. Wellington Management Group LLP grew its position in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after acquiring an additional 1,440,269 shares during the last quarter. Duquesne Family Office LLC bought a new position in Docusign in the first quarter valued at about $87,477,000. Pacer Advisors Inc. raised its stake in Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock worth $95,017,000 after acquiring an additional 1,038,962 shares in the last quarter. Finally, Third Point LLC bought a new position in shares of Docusign in the second quarter worth about $48,681,000. 77.64% of the stock is owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.